HIMS Co., Ltd. is a South Korean manufacturer of machine vision, optical inspection, and automation equipment headquartered in Incheon. Founded in 1999, the company develops and supplies inspection modules and machines for the display, semiconductor, and factory-automation (FA) industries. It is best known for OLED display equipment, including divided/fine metal mask (FMM) related machines, welders, inspection systems, and repair equipment used in the organic deposition process by global display panel makers. HIMS also produces vision modules and vision components and has expanded into AI/deep-learning-based inspection and smart factory solutions. The company is listed on the KOSDAQ market under ticker 238490.
HIMS (Health) is publicly traded
This company is no longer available on our private secondary market. Shares can be traded publicly under its listed ticker.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
1999
Employees
201–500
Total Funding
$157M
3 rounds
Latest Valuation
$1.1B
January 28, 2019
Total raised $157M across 3 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Last updated 06-25-2026
Latest Round
Type
Series C
Date
January 28, 2019
Amount
$100M
Valuation
$1.1B
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| January 28, 2019 | Series C | $100M | $1.1B | |
| June 28, 2018 | Series B | $50M | — | |
| November 2, 2017 | Series A | $7M | — | Thrive Capital, Forerunner Ventures |
Ju Hoan Kim
Chief Executive Officer
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Teladoc Health
Leading telehealth platform with 52M+ members, offering virtual medical visits, chronic care programs, and BetterHelp online therapy services.
Amazon One Medical
Amazon-backed primary care platform with integrated telehealth services offering pay-per-visit consultations ($29-$49) in direct competition with Hims.
Ro (Roman)
Direct-to-consumer telehealth platform offering consultations and prescription delivery services across multiple medical specialties.
CVS Caremark
Pharmacy Benefits Manager expanding digital health services; becoming a more direct competitor as CVS continues digitalization efforts.
Nurx
Digital health platform offering telehealth consultations and prescription delivery services primarily focused on women's health.
Lemonaid Health
Online telehealth platform providing virtual consultations and prescription delivery services for common health conditions.
Hims & Hers Health completed its merger with Oaktree Acquisition Corp. (SPAC) and began trading on the New York Stock Exchange under ticker HIMS on January 21, 2021. The company is a publicly traded, multi-specialty telehealth platform with over 2.5 million subscribers and achieved 59% revenue growth in 2025, reaching approximately $2.35B in annual revenue.
HIMS (Health) shares can be purchased through any standard brokerage account — including Fidelity, Charles Schwab, TD Ameritrade, and online platforms like Robinhood or E*TRADE. Search for the ticker to place an order.
HIMS (Health) had a valuation of approximately $1.1B at the time of its public offering. Current market capitalization fluctuates with the share price.
HIMS (Health) raised $157M across 3 disclosed funding rounds prior to its public listing.
HIMS (Health) is headquartered in Incheon, South Korea.
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.